ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2025

TL1A Inhibition in Inflammatory Bowel Disease: A Pipeline Review.

Virginia Solitano et al.PubMed ↗Publisher ↗

No numbers read from the abstract.